Articles

Targeting shear gradient activated von Willebrand factor by the novel single-chain antibody A1 reduces occlusive thrombus formation in vitro

Baker Heart and Diabetes Institute, Melbourne; TH and AR contributed equally to this work
Australian Centre for Blood Diseases, Monash University, Melbourne; TH and AR contributed equally to this work
Australian Centre for Blood Diseases, Monash University, Melbourne
Baker Heart and Diabetes Institute, Melbourne; Australian Centre for Blood Diseases, Monash University, Melbourne
Applied Stem Cell Technologies, University of Twente, Enschede; BIOS Lab-on-a-Chip, University of Twente, Enschede
ACRF Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, Australian National University, Canberra
Australian Centre for Blood Diseases, Monash University, Melbourne
Applied Stem Cell Technologies, University of Twente, Enschede
Baker Heart and Diabetes Institute, Melbourne; Australian Centre for Blood Diseases, Monash University, Melbourne
Baker Heart and Diabetes Institute, Melbourne; Australian Centre for Blood Diseases, Monash University, Melbourne; CEH and EW contributed equally to this work
Haematologica Early view Sep 21, 2020 https://doi.org/10.3324/haematol.2020.250761